Global Genetic Testing Market Research Report 2021: Market Shows Slow Growth During COVID-19, Set to Record Exponential Growth After COVID – ResearchAndMarkets.com



DUBLIN – (COMMERCIAL THREAD)–The “Genetic testing – Trajectory and analysis of the world market” report was added to ResearchAndMarkets.com offer.

Global Genetic Testing Market To Reach $ 17.3 Billion By 2026

Amid the COVID-19 crisis, the global genetic testing market estimated at US $ 10.6 billion in 2020 is expected to reach a revised size of US $ 17.3 billion by 2026, growing to 8.6% CAGR during the analysis period.

Prenatal and newborn, one of the segments analyzed in the report, is expected to register a CAGR of 8.8% and reach $ 6.4 billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and the induced economic crisis, the growth of the Diagnostics segment is readjusted to a revised CAGR of 8.2% for the next 7 year period. Globally, the prenatal testing market is expected to increase due to the increasing risk of chromosomal abnormalities associated with increasing maternal age.

One of the main drivers of the growth of neonatal and prenatal genetic testing is increased awareness of different chromosomal and genetic disorders. The development of health technologies like HTS and next-generation sequencing have made it possible to detect a number of abnormalities at an early stage. Diagnostic genetic tests detect the presence of a certain genetic disease, such as Huntington’s disease or cystic fibrosis, by detecting a specific genetic alteration.

The increasing accessibility and acceptance of untargeted sequencing among patients and consumers is expected to provide a significant boost to the market. Applications such as molecular profiling of tumors such as liquid biopsies to select anti-cancer treatment, non-invasive prenatal diagnostics and sequencing for the diagnosis of rare diseases have considerable value.

The market is poised to benefit from the growing popularity of DTP tests for specific health risks, such as 3 BRCA mutations. Another driver of the market is the proliferation of hybrid labs combining DTCs and conventional labs.

Main topics covered:

I. METHODOLOGY

II. ABSTRACT

1. MARKET OVERVIEW

  • Overview of the influencer market

  • Global market trajectories

  • Impact of Covid-19 and an impending global recession

  • A prelude to genetic testing

  • The top ten genetic diseases in the world

  • The different types of genetic testing include

  • Prenatal and newborn screening

  • Diagnostic tests

  • Predictive and presymptomatic tests

  • Identification of the carrier

  • Pharmacogenomic tests

  • List of genetic disorders by event, genetic manifestation and prevalence

  • Genetic testing delivery models

  • Genetic sequencing approaches

  • Genetic Testing Market Grows Slowly During COVID-19, Set to Record Exponential Growth After COVID

  • Develop applications to stimulate the genetic testing market

  • Regional landscape

  • The market for prenatal testing will grow

  • Market outlook

2. FOCUS ON SOME PLAYERS (Total 249 featured)

  • Recent market activity

  • Brands of the world

  • New arrivals

  • 23andMe, Inc.

  • Abbott Laboratories

  • AutoGenomics, Inc.

  • Biocartis SA

  • BioRad Laboratories

  • Cepheid Inc.

  • ELITech SAS Group

  • Illumina, Inc.

  • Corporation of America Holdings Laboratory

  • Luminex Company

  • Natera, Inc.

  • PerkinElmer, Inc.

  • QIAGEN SA

  • Quest Diagnostics, Inc.

  • Roche Diagnostics SA

  • Roche Molecular Diagnostics, Inc.

  • Thermo Fisher Scientific Inc.

3. MARKET TRENDS AND FACTORS

  • Studies indicate possible correlation between genetic variations related to immunity and severity of COVID-19

  • SECTOR ANALYSIS

  • Prenatal Screening – Changing the World of Pregnancy Care

  • List of antenatal screening and diagnostic tests available by indication

  • Prenatal and Neonatal Genetic Testing Market Players

  • Conventional Invasive Prenatal Diagnostic Techniques – A Risky Business

  • Emergence of non-invasive prenatal diagnosis (DPNI)

  • Competition intensifies in the NIPD market

  • Selection of commercially available NIPD (genetic) tests for aneuploidy in the United States

  • Resource pressure prevents widespread adoption of extended carrier sequencing

  • Predictive diagnostics

  • The market for genetic breast cancer tests will grow strongly

  • Myriad Genetics – A leader in breast cancer screening

  • Discovery of new biomarkers essential for predictive diagnosis

  • The development of pharmacogenomics promotes the growth of the genetic testing market

  • MARKET TRENDS AND GROWTH DRIVERS

  • Genetic testing paves the way for personalized medicine

  • Next Generation Sequencing (NGS) – A giant leap in genome sequencing

  • Discovery of biomarkers leads to advanced genetic testing

  • Select the list of available tumor markers

  • Huge popularity of ancestry tests

  • Increased focus on data renewal

  • Genetic testing to explode into provider workflow with intriguing use cases

  • Main factors responsible for the decline in interest in genetic tests aimed at direct consumers

  • Liquid biopsy to aid in cancer diagnosis and treatment

  • Hybrid laboratories to bridge the gap between traditional models and DTC

  • Rising prevalence of cancer and chromosomal disorders increases demand for cell-free DNA testing

  • Emergence of rapid DNA tests

  • Oncology – A key area for genetic testing

  • Aging demographics to drive demand for genetic testing

4. WORLD MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • UNITED STATES

  • Using genomic data in clinical settings to accelerate the pace

  • The United States: the world’s largest market for genetic testing

  • Predictive screening: another area of ​​growth

  • The growing relevance of personalized medicine bodes well

  • Rising cancer incidence in the United States: driving force behind cancer genetic testing

  • Estimated number of new cancer cases and deaths in the United States (2019)

  • Newborn screening is gaining ground

  • Invasive prenatal diagnosis gives way to non-invasive prenatal testing

  • Coverage of NIPT in medium-risk pregnancies expands target market

  • Direct consumer testing: a growing market

  • Favorable refund policies

  • Favorable insurance coverage for genetic testing for cystic fibrosis

  • Demographic changes offer opportunities for growth

  • Skepticism Limits Widespread Uptake of Genetic Testing

  • Competition overview

  • Myriad Eyes Diversification and expansion for growth

  • Natera holds the fort in the NIPT market

  • Invitae Banks on Low Cost Solutions to Increase Revenue

  • Regulatory environment

  • Genetic Information Non-Discrimination Act Boosts Genetic Testing

  • Stricter regulations for genetic testing for DTP

  • FDA tries to curb unapproved DTP genetic testing

  • Select the reimbursement codes for genetic tests

  • Market analysis

  • CANADA

  • Rising incidence of chronic disease drives demand for genetic testing

  • Number of new cancer cases in Canada: 2019

  • Regulatory scenario

  • Market analysis

  • JAPAN

  • Demographics drive market growth

  • DTP genetic testing regulatory scenario

  • CHINA

  • Market Snapshot

  • China attracts domestic and foreign players

  • Strong focus on genomics

  • Genetic Testing To Reveal True Talent In Children – A Popular New App

  • China to take the lead in the rapidly growing Asian genomics market

  • Market analysis

  • EUROPE

  • European personalized medicine market to show robust growth

  • Aging population will drive demand for genetic testing

  • Legislation / Regulatory policies in some European countries

  • Legislation governing genetic testing in certain European countries

  • Rising cancer incidence bodes well for the European genetic testing market

  • Cancer incidence in Europe: number of new cancer cases (in thousands) per site for 2018

  • GERMANY

  • Parliamentary regulations

  • UK

  • Increased support for personalized medicine to boost genetic testing

  • SMIP for pharmacogenomic testing

  • Growing need for safer prenatal diagnostic methods in the UK

  • Principles for DTP genetic testing stated by HGC

IV. COMPETITION

  • Total number of profiled companies: 249

For more information on this report, visit https://www.researchandmarkets.com/r/5z9r9o


Previous Build a Crypto Business Without Crypto Custodial Services with UTIP
Next Global Allergy Diagnostics Market Report 2021: Market To Reach $ 8.5 Billion By 2027

No Comment

Leave a reply

Your email address will not be published.